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 Conference Abstract 
A clinical trial to increase the identification, genetic counseling referral and genetic 
testing of women at risk for hereditary breast and/or ovarian cancer  
 
Cecelia Bellcross, PhD, MS, CGC, Christine Stanislaw, MS, CGC, April Hermstad, MPH, Christine Tallo, MMSc, CGC, Chelsea 
Leonard, BS  
 
Emory University School of Medicine  
 
Corresponding author:  Cecelia Bellcross  Emory University School of Medicine  1462 Clifton Road Suite 310, Atlanta, GA 30322  404-727-3281  
cbellcr@emory.edu 
 
Background: Approximately 1/300 individuals in the general population are at risk for hereditary breast and ovarian cancer due 
to an inherited mutation in the BRCA1/BRCA2 genes.  BRCA mutations are associated with dramatically increased risks for 
breast cancer, especially at younger ages, in addition to ovarian cancer.  Enhanced screening and risk reduction strategies can 
significantly reduce associated morbidity and mortality. The United States Preventive Services Task Force (USPSTF) 
recommends identifying women at-risk for BRCA mutations for receipt of genetic counseling and if appropriate, testing. The 
Breast Cancer Genetics Referral Screening Tool (B-RST) is a validated screen endorsed by USPSTF to facilitate this process.  
This implementation study seeks to evaluate the most effective means of follow-up for screen-positive women to maximize the 
number who are referred to, and receive, cancer genetic counseling (CGC) services.    
 
Methods: B-RST (v3.0) was used in three Emory Healthcare breast-imaging centers.  Screen-positive women were randomized 
into three methods of follow-up (patient initiated, physician notification, or staff phone call).  Primary outcomes were to compare 
the number of screen positive individuals who were referred for, scheduled, and completed a CGC appointment among the three 
groups.  
 
Results: Of 3,419 women approached, 63% participated and 579 (27%) screened positive. Appointments were scheduled by 7% 
of Group 1 participants, 17% of Group 2 individuals, and 11% of Group 3 (p<0.001).  Scheduling challenges included physician 
non-response to notification and unsuccessful direct contact. Of those scheduled, 73% completed the CGC appointment.  
 
Conclusions: Genomic medicine is receiving increased attention in the public health arena. Screening with B-RST 3.0 in 
mammography settings can improve identification of individuals at-risk for BRCA mutations and facilitate referral to CGC 
services. Despite B-RST’s ability to easily and accurately identify individuals appropriate for CGC, additional strategies are 
needed to facilitate completion of CGC in routine clinical practice.   
 
Key words: cancer genetic counseling, hereditary breast and ovarian cancer, BRCA 
 
https://doi.org/10.21633/jgpha.7.125 
 
 
 
© Cecelia Bellcross, Christine Stanislaw, April Hermstad, Christine Tallo, and Chelsea Leonard. Originally published in jGPHA 
(http://www.gapha.org/jgpha/) December 20, 2107. This is an open-access article distributed under the terms of the Creative Commons 
Attribution Non-Commercial No-Derivatives License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, 
distribution, and reproduction in any medium, provided the original work ("first published in the Journal of the Georgia Public Health 
Association…") is properly cited with original URL and bibliographic citation information. The complete bibliographic information, a link to 
the original publication on http://www.gapha.jgpha.org/, as well as this copyright and license information must be included. 
 
J Ga Public Health Assoc (2017), Vol. 7, No. 1 ISSN: 2471-9773
http://www.gapha.org/jgpha/         67 Georgia Public Health Association
67
Bellcross et al.: A Clinical Trial to Increase the Identification, Genetic Counseli
Published by Digital Commons@Georgia Southern, 2017
